Healthcare provider profile · identity verified

Farruque Ahmed, MD

Internal Medicine · BROOKLYN, NY · NPI 1265475974

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Simvastatin	Simvastatin	894	282
Amlodipine Besylate	Amlodipine Besylate	749	222
Atorvastatin Calcium	Atorvastatin Calcium	453	138
Metoprolol Succinate	Metoprolol Succinate	399	118
Hydrochlorothiazide	Hydrochlorothiazide	299	92
Losartan Potassium	Losartan Potassium	295	92
Albuterol Sulfate Hfa	Albuterol Sulfate	290	91
Metformin Hcl	Metformin Hcl	289	85
Omeprazole	Omeprazole	223	83
Eliquis	Apixaban	197	58
Furosemide	Furosemide	197	65
Glipizide Er	Glipizide	192	57
Levothyroxine Sodium	Levothyroxine Sodium	181	57
Alendronate Sodium	Alendronate Sodium	176	51
Montelukast Sodium	Montelukast Sodium	152	55
Lisinopril	Lisinopril	141	45
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	129	34
Atenolol	Atenolol	124	35
Tamsulosin Hcl	Tamsulosin Hcl	121	36
Metformin Hcl Er	Metformin Hcl	120	38
Diclofenac Sodium	Diclofenac Sodium	113	40
Carvedilol	Carvedilol	109	32
Nifedipine Er	Nifedipine	106	30
Rosuvastatin Calcium	Rosuvastatin Calcium	102	35
Meloxicam	Meloxicam	101	33
Fluticasone Propionate	Fluticasone Propionate	100	48
Metoprolol Tartrate	Metoprolol Tartrate	91	27
Allopurinol	Allopurinol	90	30
Azithromycin	Azithromycin	86	79
Irbesartan	Irbesartan	86	28
Gabapentin	Gabapentin	80	34
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	79	21
Clopidogrel	Clopidogrel Bisulfate	77	28
Synthroid	Levothyroxine Sodium	77	23
Glipizide	Glipizide	68	19
Jardiance	Empagliflozin	68	25
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	66	21
Azelastine Hcl	Azelastine Hcl	65	23
Meclizine Hcl	Meclizine Hcl	65	31
Potassium Chloride	Potassium Chloride	64	22
Fluocinonide	Fluocinonide	62	29
Pantoprazole Sodium	Pantoprazole Sodium	60	26
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	60	16
Enalapril Maleate	Enalapril Maleate	56	17
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	56	17
Januvia	Sitagliptin Phosphate	55	16
Janumet	Sitagliptin Phos/Metformin Hcl	54	14
Vitamin D2	Ergocalciferol (Vitamin D2)	54	19
Finasteride	Finasteride	51	14
Ciprofloxacin Hcl	Ciprofloxacin Hcl	50	43
Donepezil Hcl	Donepezil Hcl	50	18
Valsartan	Valsartan	49	15
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	48	13
Triamcinolone Acetonide	Triamcinolone Acetonide	48	23
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	42	24
Repaglinide	Repaglinide	40	12
Amoxicillin	Amoxicillin	39	35
Ozempic	Semaglutide	37	suppressed
Pravastatin Sodium	Pravastatin Sodium	35	11
Single Use Swab	Alcohol Antiseptic Pads	35	14
Ropinirole Hcl	Ropinirole Hcl	34	suppressed
Alprazolam	Alprazolam	32	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	32	suppressed
Glimepiride	Glimepiride	31	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	27	suppressed
Novolog Flexpen	Insulin Aspart	27	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	27	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	26	suppressed
Hydralazine Hcl	Hydralazine Hcl	26	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	25	suppressed
Ezetimibe	Ezetimibe	25	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	25	suppressed
Hydrocortisone	Hydrocortisone	25	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	25	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	24	15
Warfarin Sodium	Warfarin Sodium	24	suppressed
Colchicine	Colchicine	23	suppressed
Gavilyte-G	Peg3350/Sod Sulf,bicarb,cl/Kcl	23	22
Levemir Flexpen	Insulin Detemir	23	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Famotidine	Famotidine	22	suppressed
Labetalol Hcl	Labetalol Hcl	22	suppressed
Cefuroxime	Cefuroxime Axetil	20	18
Diazepam	Diazepam	20	suppressed
Farxiga	Dapagliflozin Propanediol	20	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	20	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	20	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	19	suppressed
Spironolactone	Spironolactone	19	suppressed
Valacyclovir	Valacyclovir Hcl	19	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	19	suppressed
Nitroglycerin	Nitroglycerin	18	suppressed
Ammonium Lactate	Ammonium Lactate	17	suppressed
Clonidine Hcl	Clonidine Hcl	17	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	17	suppressed
Levetiracetam	Levetiracetam	17	suppressed
Pregabalin	Pregabalin	17	suppressed
Tizanidine Hcl	Tizanidine Hcl	17	suppressed
Entresto	Sacubitril/Valsartan	16	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	16	suppressed
Mupirocin	Mupirocin	16	12
Propranolol Hcl Er	Propranolol Hcl	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	14
Benazepril Hcl	Benazepril Hcl	15	suppressed
Lovastatin	Lovastatin	14	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Procto-Med Hc	Hydrocortisone	14	suppressed
Clindamycin Hcl	Clindamycin Hcl	13	suppressed
Mometasone Furoate	Mometasone Furoate	13	suppressed
Terazosin Hcl	Terazosin Hcl	13	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Erythromycin-Benzoyl Peroxide	Erythromycin/Benzoyl Peroxide	12	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Prednisone	Prednisone	12	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Calcitriol	Calcitriol	11	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	11	suppressed
Gavilyte-C	Peg3350/Sod Sulf,bicarb,cl/Kcl	11	11
Nystatin	Nystatin	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Pro Comfort Alcohol Pads	Alcohol Antiseptic Pads	11	suppressed
Sertraline Hcl	Sertraline Hcl	11	suppressed
Tresiba Flextouch U-200	Insulin Degludec	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error